BioNTech (NASDAQ:BNTX) Rating Reiterated by HC Wainwright
BioNTech (NASDAQ:BNTX – Get Free Report)‘s stock had its “buy” rating restated by analysts at HC Wainwright in a research report issued on Wednesday, Benzinga reports. They currently have a $113.00 price objective on the stock. HC Wainwright’s price objective would suggest a potential upside of 40.58% from the stock’s previous close. A number of […]
More Stories
Cerity Partners LLC Purchases 249,475 Shares of Bristol-Myers Squibb (NYSE:BMY)
Cerity Partners LLC increased its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 38.9% in the third...
Stryker Co. (NYSE:SYK) Shares Bought by Larson Financial Group LLC
Larson Financial Group LLC grew its holdings in Stryker Co. (NYSE:SYK – Free Report) by 3.4% in the 3rd quarter,...
Larson Financial Group LLC Has $5.87 Million Holdings in Fidelity Total Bond ETF (NYSEARCA:FBND)
Larson Financial Group LLC boosted its position in Fidelity Total Bond ETF (NYSEARCA:FBND – Free Report) by 1,376.5% during the...
SPDR Gold MiniShares Trust (NYSEARCA:GLDM) Shares Purchased by Managed Asset Portfolios LLC
Managed Asset Portfolios LLC raised its stake in SPDR Gold MiniShares Trust (NYSEARCA:GLDM – Free Report) by 0.5% in the...
Centaurus Financial Inc. Sells 2,808 Shares of iShares Global 100 ETF (NYSEARCA:IOO)
Centaurus Financial Inc. trimmed its holdings in iShares Global 100 ETF (NYSEARCA:IOO – Free Report) by 2.4% in the 3rd...
Centaurus Financial Inc. Buys 59,729 Shares of SoFi Enhanced Yield ETF (NYSEARCA:THTA)
Centaurus Financial Inc. lifted its stake in shares of SoFi Enhanced Yield ETF (NYSEARCA:THTA – Free Report) by 16.9% during...